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Background: Prolonged storage of red blood cells (RBCs) leads to fundamental changes in both the RBCs and the
storage media. We retrospectively evaluated the relationship between the RBC age and in-hospital and long-term
postoperative outcomes in patients undergoing off-pump coronary artery bypass.
Methods: The electronic medical records of 1,072 OPCAB patients were reviewed and information on the transfused
RBCs and clinical data were collected. The effects of RBCs age (mean age, oldest age of transfused RBCs, any RBCs older
than 14 days) on various in-hospital postoperative complications and long-term major adverse cardiovascular and
cerebral events over a mean follow-up of 31 months were investigated. Correlations between RBCs age and duration
of intubation, intensive care unit, or hospital stay, and base excess at the first postoperative morning were also analyzed.
Results: After adjusting for confounders, there was no relationship between the RBCs age and in-hospital and long-term
clinical outcomes except for postoperative wound complications. A significant linear trend was observed between the
oldest age quartiles of transfused RBCs and the postoperative wound complications (quartile 1 vs. 2, 3 and 4: OR, 8.92,
12.01 and 13.79, respectively; P for trend = 0.009). The oldest transfused RBCs showed significant relationships with a
first postoperative day negative base excess (P = 0.021), postoperative wound complications (P = 0.001), and length of
hospital stay (P = 0.008).
Conclusions: In patients undergoing off-pump coronary artery bypass, the oldest age of transfused RBCs were
associated with a postoperative negative base excess, increased wound complications, and a longer hospital stay,
but not with the other in-hospital or long-term outcomes.
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Prolonged storage of red blood cells (RBCs) alters them
and their storage media, causing changes referred to as
‘storage lesions’. Over time, intracellular adenosine tri-
phosphate within the stored RBCs decreases, rendering
the RBC membrane fragile and less deformable [1]. The
breakdown of fragile RBCs releases free hemoglobin and
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unless otherwise stated.leading to vasoconstriction, thrombosis, and inflammation
[2,3]. Moreover, depleted 2,3 DPG decreases oxygen deli-
very to organs [4]. Numerous studies on various patient
populations have investigated the clinical impact of RBC
storage lesions. However, their impact is still debatable.
Several studies on cardiac surgery patients have inves-
tigated the association between clinical outcomes and
the storage time of RBCs [5-9]. However, previous studies
used heterogeneous populations that included patients
who received open heart surgery for valvular heart disease
or an on-pump coronary artery bypass. Valvular heart dis-
eases have various cardiac pathophysiologies according to. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Min et al. BMC Anesthesiology 2014, 14:95 Page 2 of 10
http://www.biomedcentral.com/1471-2253/14/95the disease type and severity. Moreover, cardiopulmonary
bypass with hypothermia is associated with inflammatory,
metabolic, and hematologic responses and various organ
injuries, making elucidation of the effects of old stored
blood in such patient populations more complex [10].
Although a few studies have investigated the clinical
effects of transfusions of old stored blood in patients
undergoing coronary artery bypass surgery with regard
to vasoconstrictive, thrombotic, and inflammatory effects
[3,5,7-9,11], to our knowledge, the effects of stored RBCs
have not been investigated exclusively in patients under-
going off-pump coronary artery bypass (OPCAB) surgery.
Although the transfusion rate of RBCs in off-pump
CABG surgery was lower than that in on-pump surgery,
more than half of the OPCAB patients still needed RBCs
transfusion [12]. In patients with coronary arterial dis-
ease, RBCs transfusion is essential for adequate oxygen
delivery. Meanwhile, old blood transfusion is a concern
in such patients because of the possible harmful vascular
effects [2,3].
We hypothesized that prolonged storage of RBCs may
be associated with adverse in-hospital and long-term
postoperative outcomes in patients undergoing OPCAB.
To evaluate this hypothesis, we retrospectively studied
the relationship between the RBC storage duration and
in-hospital clinical outcomes and long-term postopera-
tive major adverse cardiovascular and cerebral events
(MACCEs) in patients undergoing OPCAB.
Methods
The study protocol was approved by the institutional
review board of our hospital (IRB No. 1302-052-465, Seoul
National University Hospital). As this was a retrospective
study using electronic medical records, individual informed
consent was waived. We screened the computerized
medical records of 1,113 patients who underwent OPCAB
between December 2005 and May 2012 and identified
patients who received RBC transfusions during their
hospital stay. A total of 41 patients who had not received
RBC transfusions were excluded. Therefore, the final
study population included 1,072 patients.
Data collection
The electronic medical records of enrolled patients were
reviewed and pre-, intra-, and postoperative data were
collected by researchers who were not aware of the RBC
transfusion information. The clinical follow-up concluded
in September 2012, with a mean follow-up duration of 31
(inter-quartile range [IQR], 11–51) months.
To determine the quantity and age of RBCs, information
about all RBC units transfused to enrolled patients during
their hospital stay was obtained from the computerized
database of our institutional blood bank with the aid of
the hospital’s Medical Information Department. Thestorage time (in days) of RBCs was analyzed in three ways:
(1) the mean age of transfused RBCs units, (2) the oldest
age of transfused RBCs units, and (3) any transfusion of
RBCs units older than 14 days as a categorical variable.
All RBCs units were provided by the Korean Red
Cross Blood Services. The RBCs were stored in citrate
phosphate dextrose adenine (CPDA)-1 and the storage
temperature was 2–6°C. RBCs units in our institution’s
blood bank are discarded after 35 days of storage. The
perioperative coagulation management strategy was as
follows: all patients took aspirin until the day of the surgery
and resumed it as soon as possible after the surgery, usually
one day postoperatively. During the surgery, the patients
were given an initial dose of heparin (1.5 mg/kg) and peri-
odic supplemental doses to maintain an ACT >300 sec.
Heparin was neutralized at the end of the surgery to only
one-third of the required protamine dose. The periopera-
tive target hemoglobin level was 10 g/dl.
Study end points and definition
The primary endpoint was the in-hospital and long-term
MACCEs, defined as a composite of death from cardiac
causes, myocardial infarction (MI), coronary revasculari-
zation, and stroke. The long-term follow-up was initiated
after hospital discharge and concluded in September 2012.
The mean follow-up period was 31 months, with the range
0 to 80 months (median 29, inter-quartile range [IQR],
11–51 months). Other study endpoints were in-hospital
postoperative adverse outcomes including all-cause
mortality, new renal failure, respiratory complications,
postoperative wound complications, a new arrhythmia
requiring treatment, bleeding-related reoperations, and
the length of ICU and hospital stay. Definitions of each
in-hospital postoperative outcome are as follows; Death
was considered to be of cardiac origin if attributed to
myocardial infarction, cardiac arrhythmia, or heart fail-
ure caused primarily by a cardiac problem. MI or stroke
diagnosis and coronary revascularization were confirmed
by reviewing hospital records. Respiratory complications
included prolonged ventilator support (>48 h) or post-
operative pneumonia. The diagnosis of pneumonia was
based on a combination of physical signs and a chest
X-ray and often confirmed by microbiological tests. Post-
operative new renal failure was defined as an increase
of >50% in serum creatinine from the preoperative
value or the requirement for new renal replacement
therapy regardless of serum creatinine level. Postoperative
wound complication was defined as any sternal wound
complication after surgery such as superficial and deep
sternal wound including mediastinitis. Arrhythmias other
than atrial fibrillation were defined as a postoperative
new arrhythmia requiring treatment, including frequent
multifocal premature ventricular contractions, ventricular
bigemini or quadrigemini, junctional rhythm, paroxysmal
Table 1 Baseline and operative characteristics
Patient variables
Number of patients 1072
Age, yr 65 (9)
Male 766 (71.5%)
Body mass index (kg m−2) 25 (3)
Diabetes mellitus 528 (49.3%)
Hypertension 771 (71.9%)
Dyslipidemia 246 (22.9%)
Previous myocardial infarction 86 (8.0%)
Previous stroke 155 (14.5%)
Acute renal failure 17 (1.6%)
Chronic renal failure 156 (14.6%)
LV dysfunction (EF < 35%) 151 (14.1%)
COPD 12 (1.1%)
Previous cardiac surgery 35 (3.3%)
Preoperative IABP insertion 218 (20.3%)
Operative variables
Emergent operation 181 (16.9%)
Number of coronary grafts 3 (1)
Duration of surgery, min 370 (77)
Data are presented as mean (SD) or number (%).
LV, left ventricle; EF, ejection fraction; COPD, chronic obstructive pulmonary
disease; IABP, intra-aortic balloon pump.
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tricular fibrillation and asystole. Bleeding-related reopera-
tion was confirmed by reviewing hospital records.
Statistical analysis
Continuous variables are presented as the mean (SD)
and categorical variables as numbers and percentages.
Linearity assumptions in the continuous variables were
examined using restricted cubic splines. After checking
for violation of the proportional hazard assumption, Cox
proportional hazards regression models were used to
identify the univariate and multivariable covariates asso-
ciated with long-term MACCEs. Hazard ratios (HRs)
and 95% confidence intervals (CIs) were calculated for
each factor using Cox proportional hazards analysis. To
assess the independent impact of each risk factor on
various postoperative outcomes, univariate and multivar-
iable logistic regression models were constructed.
Variables that included as risk factors for adverse post-
operative outcomes were as follows: total number of
transfused RBCs, patient’s age, sex, body mass index,
presence of diabetes mellitus, hypertension, dyslipidemia,
previous history of myocardial infarction, previous his-
tory of stroke, presence of renal failure, left ventricular
dysfuction (LV ejection fraction less than 35%), chronic
obstructive pulmonary disease, cardiac reoperation, peri-
operative IABP insertion, emergency operation and the
duration of surgery. In the Cox regression model for
MACCEs, perioperative use of statin, anesthetic agent,
lowest values of intraoperative hemodynamic variables
and lowest hematocrit were also included as covariates.
All adjusted models were constructed using the forward
variable selection method and a forward selection criter-
ion for model fit of P =0.1 was used. To determine the
effect of RBC age on in-hospital and long-term clinical
outcomes, we constructed each adjusted model including
each RBC age as a covariate after forward variable selec-
tion although they showed insignificant results in the
univariate analysis.
Pearson’s correlation or Spearman’s rank correlation
coefficients were used as appropriate to analyze the rela-
tionships between RBC transfusion amount and some
continuous variables such as postoperative base excess,
total bilirubin, length of ICU and hospital stay. Partial
correlation analyses were used to remove the effects of
the number of transfused RBCs in the relationships
between the three ages of RBCs and those continuous
variables. A P value of <0.05 was considered to indicate
statistical significance. Analyses were performed using
SPSS 19.0 (SPSS, Chicago, IL).
Results
Baseline and operative characteristics of the 1,072 patients
studied are shown in Table 1. Although there was a maledominance (71.6%), there was no sex-related difference in
the transfused RBCs amounts. A total of 7,480 allogenic,
non-leukoreduced RBC units were transfused in the 1,072
patients. The mean storage time of the transfused RBCs
was 11.7 (5.2) days (range, 0–35 days); the distribution of
the storage time of all transfused RBCs units is shown in
Figure 1. The average number of transfused RBCs per
patient was 7 (8) units and the distribution of the number
of transfused RBCs and the average values of RBCs age
according to the number of transfused RBCs units are
shown in Figure 2. In all, 473 patients (44%) received at
least one RBC unit that was older than 14 days.
Long-term MACCEs
MACCEs occurred in 16.9% (181/1072) of patients during
the follow-up period, including 15 deaths from cardiac
causes, 48 myocardial infarctions, 88 coronary revasculari-
zations, and 44 strokes. Some patients had more than one
complication. The detailed description of the components
of MACCEs was presented in the Additional file 1. In uni-
variate analysis, MACCEs were significantly associated
with the amount of RBCs transfused but not with the
storage time of RBCs (Table 2). After adjusting for the
variables with P <0.1 in the univariate analyses, total
number of transfused RBCs (HR, 1.03; 95% CI, 1.02–
1.04; P <0.001), and the use of postoperative statin (HR,
Figure 1 Storage age of all transfused RBCs. The figure shows the distribution of RBCs age and the number of transfusions for each RBCs age.
RBC, red blood cell.
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nificantly associated with MACCEs. We constructed
separate adjusted models including those two significant
factors and the age of RBCs as covariates, which revealed
no significant association between RBCs age and long-
term MACCEs (Table 2).
In-hospital complications
The incidence of each postoperative clinical outcome is
presented in Table 3. The oldest transfused RBCs were
strongly associated with all of the in-hospital postoperative
adverse outcomes except for MACCEs in the univariate
analyses but the predictive effects disappeared in multi-
variable analyses adjusting for confounders, except for
postoperative wound complications (Table 3, see also
Additional file 2). For postoperative wound complications,Figure 2 Transfusion amounts per patient and its relationship with th
amounts. In each number of transfusions, squares (□) represent the averag
the average value of ‘mean age of transfused RBCs’. RBC, red blood cell.oldest age of transfused RBCs (OR, 1.09; 95% CI, 1.04–
1.14; P =0.001), total number of transfused RBCs (OR,
1.03; 95% CI, 1.01–1.06; P =0.001), presence of diabetes
mellitus (OR, 1.96; 95% CI, 1.05–3.67; P =0.035), and
body mass index (OR, 1.14; 95% CI, 1.03–1.25; P =0.008)
were significantly associated on multivariable analysis
(Additional file 2). The number of transfused RBCs was
significantly correlated with all of the analyzed clinical
outcomes even after adjusting for confounding parameters
(Table 3, Additional file 2). Mean age of transfused RBCs
was not significantly related with any of the postoperative
clinical outcomes. A significant association between ‘any
RBCs unit >14 days’ and some postoperative outcomes
(postoperative wound complications and bleeding-related
reoperation) disappeared after adjusting for confounders
(Table 3).e RBCs age. Bars represent the number of cases for each transfusion
e value of ‘oldest age of transfused RBCs’ and triangles (△) represent
Table 2 Predictors for MACCEs
Univariable analysis Adjusted model 1* Adjusted model 2† Adjusted model 3‡
HR 95% CI P value HR 95% CI P value HR 95% CI P value HR 95% CI P value
Total number of RBCs transfusion 1.04 1.03-1.05 <0.001 1.03 1.02-1.04 <0.001 1.03 1.02-1.04 <0.001 1.03 1.02-1.04 <0.001
Mean RBCs age 0.97 0.94-1.00 0.053 0.98 0.95-1.01 0.248
Maximum RBCs age 1.01 0.99-1.04 0.368 1.001 0.97-1.03 0.948
Any RBCs unit >14 days 1.01 0.75-1.35 0.957 0.89 0.65-1.24 0.504
Age 1.03 1.01-1.04 0.005
Male 0.94 0.68-1.28 0.679
Body mass index (kg m−2) 0.99 0.95-1.04 0.652
Smoking 0.92 0.69-1.23 0.563
Diabetes mellitus 0.9 0.67-1.21 0.493
Hypertension 1.4 0.99-1.98 0.059
Dyslipidemia 1.13 0.81-1.58 0.47
Previous myocardial infarction 1.05 0.62-1.78 0.852
Previous stroke 1.27 0.87-1.88 0.221
Acute renal failure 1.97 0.73-5.33 0.179
Chronic renal failure 1.6 1.1-2.34 0.015
LV dysfunction (EF < 35%) 1.46 0.99-2.14 0.053
COPD 2.83 1.05-7.62 0.04
Previous cardiac surgery 1.24 0.58-2.65 0.572
Perioperative IABP insertion 1.77 1.30-2.40 <0.001
Emergent operation 1.59 1.13-2.24 0.008
Duration of surgery (min) 1 1.00-1.00 0.093
preoperative statin use 0.88 0.65-1.17 0.35
postoperative statin use 0.49 0.32-0.75 0.001 0.56 0.37-0.85 0.007 0.56 0.37-0.86 0.007 0.56 0.37-0.85 0.006
anesthetics (sevoflurane vs. propofol) 0.82 0.59-1.15 0.26
lowest intraoperative heart rate 0.99 0.98-1.01 0.828




lowest intraoperative cardiac index 0.8 0.48-1.35 0.4
lowest perioperative hematocrit 0.97 0.92-1.01 0.129
*Adjusted model 1 was constructed including the mean RBCs age as a covariate.
†Adjusted model 2 was constructed including the oldest RBCs age as a covariate.
‡Adjusted model 3 was constructed including the ‘any RBCs unit >14 days’ as a covariate.
MACCE, major adverse cardiovascular and cerebral event; RBC, red blood cell; LV, left ventricle; EF, ejection fraction; COPD, chronic obstructive pulmonary disease;
IABP, intra-aortic balloon pump.
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Total number of transfused RBCs was significantly
related with the duration of ICU stay (r =0.47, P <0.001),
and hospital stay (r =0.58, P <0.001). After controlling
for the effects of the number of transfused RBCs, the
oldest transfused RBCs were significantly correlated
with the length of hospital stay (r =0.08, P =0.008) but
not with the length of ICU stay (Table 4). There was no
significant relationship between the other ages of RBCs
and the ICU or hospital length of stay (Table 4).Postoperative base excess
We evaluated the relationship between RBCs age and
base excess on first postoperative morning. After adjusting
for the transfusion amount, the oldest transfused RBCs
showed a significant negative correlation with the post-
operative base excess (r = −0.08, P =0.02). There were
no significant relationships between the other ages of
RBCs and the base excess (with mean age of transfused
RBCs: r = −0.03, P =0.32; with any RBCs unit >14 days:
r = −0.05, P =0.16).
Table 3 The age or the number of transfused RBCs and the postoperative clinical outcomes
Univariate analysis Multivariable analysis
N (%) OR 95% CI P value OR 95% CI P value
Number of transfused RBCs
In-hospital all-cause mortality 17 (1.6) 1.1 1.07-1.14 <0.001 1.1 1.06-1.14 <0.001
In-hospital MACCEs 74 (6.9) 1.06 1.04-1.09 <0.001 1.05 1.03-1.08 <0.001
New renal failure 54 (5.0) 1.05 1.03-1.07 <0.001 1.03 1.00-1.05 0.04
Respiratory complication 33 (3.1) 1.05 1.03-1.07 <0.001 1.04 1.01-1.06 0.005
Postoperative wound complication 49 (4.6) 1.04 1.02-1.06 <0.001 1.03 1.01-1.06 0.001
Atrial fibrillation 290 (29.1) 1.04 1.02-1.06 <0.001 1.02 1.00-1.04 0.038
Arrhythmia other than atrial fibrillation 112 (10.4) 1.05 1.03-1.07 <0.001 1.03 1.02-1.05 <0.001
Bleeding-related reoperation 29 (2.7) 1.09 1.06-1.12 <0.001 1.08 1.05-1.12 <0.001
Oldest age of transfused RBCs
In-hospital all-cause mortality 1.1 1.02-1.19 0.015 1.01 0.91-1.12 0.896
In-hospital MACCEs 1.01 0.97-1.05 0.63 0.97 0.93-1.02 0.198
New renal failure 1.08 1.03-1.13 0.001 1.03 0.98-1.09 0.251
Respiratory complication 1.07 1.01-1.13 0.02 1.01 0.95-1.08 0.726
Postoperative wound complication 1.1 1.05-1.15 <0.001 1.09 1.04-1.14 0.001
Atrial fibrillation 1.03 1.00-1.05 0.022 1.01 0.99-1.04 0.339
Arrhythmia other than atrial fibrillation 1.04 1.00-1.07 0.037 1.02 0.98-1.05 0.348
Bleeding-related reoperation 1.08 1.02-1.15 0.007 1.02 0.95-1.10 0.531
Mean age of transfused RBCs
In-hospital all-cause mortality 0.93 0.84-1.04 0.23 0.95 0.82-1.09 0.446
In-hospital MACCEs 0.95 0.90-1.00 0.053 0.95 0.90-1.01 0.1
New renal failure 0.99 0.93-1.05 0.684 1.01 0.94-1.08 0.857
Respiratory complication 0.99 0.92-1.06 0.731 0.98 0.90-1.06 0.629
Postoperative wound complication 1.04 0.98-1.10 0.201 1.05 0.99-1.12 0.106
Atrial fibrillation 1 0.97-1.03 0.969 1 0.97-1.04 0.783
Arrhythmia other than atrial fibrillation 0.99 0.95-1.03 0.614 1 0.96-1.05 0.869
Bleeding-related reoperation 1.04 0.96-1.12 0.332 1.08 0.99-1.18 0.094
Any RBCs unit >14 days
In-hospital all-cause mortality 1.83 0.64-4.84 0.225 0.7 0.20-2.45 0.278
In-hospital MACCEs 1.02 0.64-1.64 0.933 0.74 0.44-1.24 0.256
New renal failure 1.5 0.87-2.60 0.148 1.05 0.57-1.97 0.869
Respiratory complication 1.54 0.77-3.09 0.224 1.06 0.50-2.27 0.878
Postoperative wound complication 1.96 1.10-3.50 0.023 1.71 0.93-3.12 0.083
Atrial fibrillation 1.2 0.92-1.58 0.18 1.06 0.80-1.41 0.675
Arrhythmia other than atrial fibrillation 1.41 0.95-2.09 0.085 1.19 0.79-1.80 0.407
Bleeding-related reoperation 2.24 1.05-4.75 0.036 1.21 0.50-2.93 0.669
RBC, red blood cell; MACCE, major adverse cardiovascular and cerebral event.
Table 4 Correlation between the transfused RBCs and intubated time, ICU stay and Hospital stay
Transfusion amout Oldest RBCs age Mean RBCs age Any RBCs unit >14 days
r P value r P value r P value r P value
ICU stay 0.47 <0.001 −0.001 0.971 −0.005 0.862 0.001 0.976
Hospital stay 0.58 <0001 0.081 0.008 0.007 0.811 0.059 0.056
RBC, red blood cell; ICU, intensive care unit.
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We evaluated the relationship between RBCs age and
the postoperative highest total bilirubin as an indicator
of hemolysis. Postoperative highest total bilirubin was
significantly correlated with the total number of trans-
fused RBCs (r =0.19, P <0.001) and the oldest age of
transfused RBCs (r =0.12, P <0.001). However, after
adjusting for the transfusion amount, the oldest age of
transfused RBCs was not significantly related with the
postoperative highest total bilirubin (r =0.06, P =0.056).
Oldest RBCs age and wound complications
As there was a significant association between the oldest
transfused RBCs and postoperative wound complications,
we constructed an additional adjusted model for postoper-
ative wound complications including the oldest age of
transfused RBCs as quartiles rather than a continuous
variable. In the adjusted model, a significant linear trend
was observed between the oldest age quartiles of trans-
fused RBCs and postoperative wound complications
(quartile 1 vs. 2: OR, 8.92; 95% CI, 1.15–69.05; quartile 1
vs. 3: OR, 12.01; 95% CI, 1.56–92.63; quartile 1 vs. 4: OR,
13.79; 95% CI, 1.82–104.76; P for trend =0.009) (Table 5).
There were two patients with other postoperative
infections other than wound and the details of those
patients were presented in the Additional file 3. We also
calculated the postoperative Sepsis related Organ Failure
(SOFA) scores [13] and analyzed the relationship with
RBCs ages. The total number of transfused RBCs and
the oldest age of the transfused RBCs showed significant
correlations with the postoperative highest SOFA scores
(see Additional file 4).
Discussion
In this retrospective study, postoperative in-hospital out-
come and long-term MACCEs were associated with the
amount of transfused RBC units in patients undergoing




Number of transfused RBCs 1.04




*P for trend refers to linear trend across lowest to highest quartile.
*Oldest age quartile 1: oldest age of transfused RBCs unit <10 days (n =218), quarti
age of transfused RBCs unit <18 days (n =254), quartile 4: oldest age of transfused
RBC, red blood cell; DM, diabetes mellitus; BMI, body mass index.of transfused RBC units was not associated with long-
term MACCEs, but was associated with postoperative
wound complications, postoperative day 1 negative base
excess, and the length of hospital stay. A linear trend was
observed between the oldest age quartiles of transfused
RBCs and postoperative wound complications.
Several studies have investigated the clinical effects of
RBC storage time in patients undergoing cardiac surgery,
including coronary artery bypass grafting (CABG). In a
previous retrospective analysis of 3,597 CABG patients,
the storage time of transfused RBCs was not a significant
predictor of early or late mortality [7] and in other retro-
spective analyses in CABG patients [5,8,14,15], early post-
operative morbidities or major adverse cardiovascular
events were not associated with RBCs age using various
methods of analysis. The results of the present study are
consistent with those earlier results in that the significant
adverse effects of older RBCs observed in an unadjusted
model disappeared after adjusting for confounding factors.
However, our study evaluated the adverse effects of older
blood on postoperative wound complications while the
previous studies did not.
In contrast to our results, a retrospective study that
included 6,002 cardiac surgery patients found that transfu-
sion of RBCs older than 14 days increased in-hospital
mortality and mechanical ventilation time, caused various
complications, and decreased long-term survival after
cardiac surgery [9]. However, several baseline charac-
teristics that were significantly different between the
newer and older blood groups (e.g., more left ventricular
dysfunction, NYHA class IV, mitral regurgitation, and
peripheral vascular disease in the older blood group)
may have affected the results. There was no difference
in the incidence of sternal wound complications between
the two groups in that study; however, approximately half
of the patients received transfusions of leukoreduced
RBCs and their study population included an unknown
ratio of on- and off-pump surgery patients. TheseAdjusted model








le 2: oldest age of transfused RBCs unit <14 days (n =304), quartile 3: oldest
RBCs unit ≥18 days (n =296).
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results. Another study reported a significant association
between RBC storage age and the morbidity and mortality
after cardiac surgery [16], but it was voluntarily retracted.
Based on the results of many previous studies of the
effects of RBCs storage, a storage time of more than
14 days is considered hazardous; thus, 14 days is often
used as the cutoff point for patient grouping [7,9,15,17].
The levels of intracellular 2,3-DPG decline to undetectable
levels by storage day 14 [3,18] but begin to normalize
within a few hours of transfusion and are completely
restored within 72 h after transfusion [19,20].
The adverse effects of RBC transfusion on postopera-
tive morbidity and mortality have been demonstrated in
numerous studies [6,21-23]. In this study, the number of
perioperative RBCs transfusions was associated with
in-hospital and long-term clinical outcomes, consistent
with previous studies. On the other hand, the clinical
adverse effects of storage time of RBCs disappeared after
adjusting for confounding factors including transfusion
amount, possibly due to RBCs breakdown that occurs
during RBCs processing regardless of RBCs age [24].
A dose-dependent adverse effect of RBCs transfusions
on postoperative wound complications has been reported
in numerous studies and increased body mass index
and diabetes mellitus have been identified as additional
risk factors [25-28]; our results are consistent with
these findings. Moreover, we found that the oldest age
of transfused RBCs was also associated with increased
postoperative wound complications. Although it is difficult
to determine the causal relationship, significant relation-
ships were observed between the oldest transfused RBCs
and the postoperative negative base excess (r = −0.079,
P =0.02), between negative base excess and postoperative
wound complications (r =−0.086, P =0.01), and between
postoperative wound complications and prolonged hospital
stay (r =0.28, P <0.001). Monitoring of the intra- and post-
operative acid–base status has been used as a surrogate
marker of tissue oxygen delivery and cellular perfusion
[29]. The negative base excess was significantly correlated
with the oldest age of transfused RBCs units, which
may be due to insufficient oxygen supply to the tissues.
This may suggest that older blood transfusions induce
tissue hypoperfusion, which increases postoperative wound
complications, consequently leading to a prolonged hos-
pital stay.
Moreover, reduced bioavailability of nitric oxide in older
RBCs units might have delayed the wound healing [3]. A
number of studies investigated the role of nitric oxide in
wound healing [30-33]. Synthesis of nitric oxide occurs
during wound healing, especially in the early stage of
healing [30], and the released nitric oxide improved
wound repair by angiogenesis, collagen formation, cell
proliferation, and fibroblast migration in damaged tissue[31-33]. Possible other explanation for increased wound
complications was transfusion-related immunomodulation
in the blood recipients, especially those receiving non-
leukoreduced RBCs [34]. A previous prospective cohort
study with trauma patients reported that prestorage leu-
koreduction abrogated the detrimental effect of old stored
blood [35]. Although the different characteristics of the
study population make it difficult to compare the findings
of that study with our results, leukoreduction might have
reduced the wound infection in our study.
This study had several limitations. Our study population
contained only coronary disease patients who underwent
OPCAB by a single surgeon in a single tertiary center.
Therefore, it was relatively more homogeneous than
populations in previous studies of cardiac surgery patients.
However, the retrospective design means that uncon-
trolled biases could have affected our analyses. As it is
difficult to randomize patients to receive older blood
transfusions due to ethical concerns and technical
problems, the results of some randomized controlled
trials of cardiac surgery patients (ClinicalTrials.gov No.:
NCT00458783 and NCT00991341) [36] awaiting publica-
tion will be important in drawing conclusions about the
effects of old stored RBCs on various clinical outcomes.
For another limitation, all transfused RBCs in this
study were from nonleukocyte-depleted blood and the
clinical effects of stored leukocyte-depleted or irradi-
ated RBCs remain unclear. Filtered RBCs unit showed
different level of RBCs hemolysis and leukocyte break-
down from unfiltered RBCs unit over time [24], and
gamma irradiation increases hemolysis of RBCs causing
potassium leakage and liberates reactive oxygen species.
Thus, further studies are needed to identify the clinical
effects of those RBCs unit.
Conclusions
Postoperative in-hospital outcome and long-term MACCEs
were associated with the amount of transfused RBC units.
The oldest transfused RBC units were associated with the
greatest incidence of postoperative wound complications,
negative base excess, and longest duration of hospital stay,
but not with the other in-hospital outcomes or long-term
MACCEs. This suggests that hypoperfused tissue caused by
the transfusion of older stored blood increases the inci-
dence of postoperative wound complications, consequently
increasing the hospital stay.Additional files
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